Johnson & Johnson (JNJ) Stock

Healthcare · Drug Manufacturers - General · Member of S&P 500, Dow Jones

Johnson & Johnson (JNJ) closed at USD 253.28 on 2026-10-15, a change of +38.8 % over the past year, with a market capitalization of USD 615.87B.

Johnson & Johnson recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Johnson & Johnson key figures

Previous close

USD 253.28 (2026-10-15)

1-year change

+38.8 %

Market cap

USD 615.87B

Enterprise value

USD 644.15B

P/E ratio (trailing)

38.78

P/E ratio (forward)

21.83

EPS (trailing)

6.59

EPS (forward)

11.71

PEG ratio

2.77

Price to book

7.24

Revenue growth

5.9 %

Earnings growth

-96 %

Dividend per share (trailing)

1.30

Short ratio

3.46

Employees

138,200

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Johnson & Johnson and compare it with other stocks.